http://www.pharmalot.com/2007/05/the-ethically-challenged-how-pharma-fares/ News, Comment and Conversation Sat, 06 Sep 2008 05:48:34 +0000 http://wordpress.org/?v=2.5.1 http://www.pharmalot.com/2007/05/the-ethically-challenged-how-pharma-fares/#comment-3605 Covalence SA » The Ethically Challenged: How Pharma Fares Sun, 03 Jun 2007 10:59:09 +0000 http://www.pharmalot.com/2007/05/the-ethically-challenged-how-pharma-fares/#comment-3605 [...] Publication about Covalence | Country: Global | Company: GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, Novartis, Pfizer, Roche, Abbott, Boehringer-Ingelheim, Merck & Co, Eli Lilly, Sanofi-Aventis | Source: Pharmalot [...] [...] Publication about Covalence | Country: Global | Company: GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson, Novartis, Pfizer, Roche, Abbott, Boehringer-Ingelheim, Merck & Co, Eli Lilly, Sanofi-Aventis | Source: Pharmalot [...]

]]> http://www.pharmalot.com/2007/05/the-ethically-challenged-how-pharma-fares/#comment-3579 sawitinaction Fri, 01 Jun 2007 01:25:39 +0000 http://www.pharmalot.com/2007/05/the-ethically-challenged-how-pharma-fares/#comment-3579 Readers must have noticed. Pfizer and Novartis have been exchanging ratings 4 and 5 in these two years. Pfizer has been all over the map in media and blogs. How come Novartis with no better ethical rating, has kept more or less low profile. No fines, no major exposure just few minor things. They must have some special skills when it comes to protecting their a.... Readers must have noticed. Pfizer and Novartis have been exchanging ratings 4 and 5 in these two years. Pfizer has been all over the map in media and blogs. How come Novartis with no better ethical rating, has kept more or less low profile. No fines, no major exposure just few minor things. They must have some special skills when it comes to protecting their a….

]]>